Rate of progression of chronic renal failure in predialysis patients treated with erythropoietin.
Clinical Research Department, RW Johnson Pharmaceutical Research Institute, Raritan, NJ 08869.
R
R
Abels
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000818:Animals; D003404:Creatinine / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin; D003404:Creatinine